Armata Pharmaceuticals Q3 EPS $(0.86) Misses $(0.31) Estimate, Sales $1.23M Beat $950.00K Estimate

Author: Benzinga Newsdesk | November 14, 2023 05:05pm
Armata Pharmaceuticals (AMEX:ARMP) reported quarterly losses of $(0.86) per share which missed the analyst consensus estimate of $(0.31) by 177.42 percent. This is a 258.33 percent decrease over losses of $(0.24) per share from the same period last year. The company reported quarterly sales of $1.23 million which beat the analyst consensus estimate of $950.00 thousand by 28.95 percent. This is a 8.45 percent decrease over sales of $1.34 million the same period last year.

Posted In: ARMP